Current and prospective computational approaches and challenges for developing COVID-19 vaccines.
Journal Information
Full Title: Adv Drug Deliv Rev
Abbreviation: Adv Drug Deliv Rev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Evidence found in paper:
"appendix a supplementary data the following are the supplementary data to this article: supplementary data 1 acknowledgement the authors would like to thank professor gordon dougan for his helpful advice and comments."
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests M.M. is an employee of LifeArc. K.C. is funded by pharmaceutical industry."
Funding Disclosure
Evidence found in paper:
"AcknowledgementThe authors would like to thank Professor Gordon Dougan for his helpful advice and comments. W.H. and N.H. are funded by LifeArc. Competing interestsM.M. is an employee of LifeArc. K.C. is funded by pharmaceutical industry."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025